Literature DB >> 23949582

The cytogenetic action of ifosfamide, mesna, and their combination on peripheral rabbit lymphocytes: an in vivo/in vitro cytogenetic study.

S Bogiatzi1, O Pagonopoulou, M Simopoulou, D Kareli, A Kouskoukis, Z Koutka, P Ipsilantis, T Lialiaris.   

Abstract

Ifosfamide (IFO) is an alkylating nitrogen mustard, administrated as an antineoplasmic agent. It is characterized by its intense urotoxic action, leading to hemorrhagic cystitis. This side effect of IFO raises the requirement for the co-administration with sodium 2-sulfanylethanesulfonate (Mesna) aiming to avoid or minimize this effect. IFO and Mesna were administrated separately on rabbit's lymphocytes in vivo, which were later developed in vitro. Cytogenetic markers for sister chromatid exchanges (SCEs), proliferation rate index (PRI) and Mitotic Index were recorded. Mesna's action, in conjunction with IFO reduces the frequency of SCEs, in comparison with the SCEs recordings obtained when IFO is administered alone. In addition to this, when high concentrations of Mesna were administered alone significant reductions of the PRI were noted, than with IFO acting at the same concentration on the lymphocytes. Mesna significantly reduces IFO's genotoxicity, while when administered in high concentrations it acts in an inhibitory fashion on the cytostatic action of the drug.

Entities:  

Year:  2013        PMID: 23949582      PMCID: PMC4158025          DOI: 10.1007/s10616-013-9624-9

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  39 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 2.  Ifosfamide: pharmacokinetic properties for central nervous system metastasis prevention.

Authors:  F Lokiec
Journal:  Ann Oncol       Date:  2006-05       Impact factor: 32.976

3.  Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.

Authors:  Koichi Ogura; Takahiro Goto; Jungo Imanishi; Yusuke Shinoda; Tomotake Okuma; Yusuke Tsuda; Hiroshi Kobayashi; Toru Akiyama; Makoto Hirata; Aiichiro Yamamoto; Hirotaka Kawano
Journal:  Int J Clin Oncol       Date:  2011-12-17       Impact factor: 3.402

4.  Effect of ifosfamide on intracellular glutathione levels in peripheral blood lymphocytes and its correlation with therapeutic response in patients with advanced ovarian cancer.

Authors:  I A Malik; N Mehboobali; M P Iqbal
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

5.  Blood thiols following amifostine and mesna infusions, a pediatric oncology group study.

Authors:  A K Souid; R C Fahey; M K Aktas; O A Sayin; S Karjoo; G L Newton; P D Sadowitz; R L Dubowy; M L Bernstein
Journal:  Drug Metab Dispos       Date:  2001-11       Impact factor: 3.922

6.  Induction of cytogenetic damage in human lymphocytes in vitro and of antineoplastic effects in Ehrlich ascites tumor cells in vivo treated by methotrexate, hyperthermia and/or caffeine.

Authors:  T Maskaleris; T Lialiaris; C Triantaphyllidis
Journal:  Mutat Res       Date:  1998-12-03       Impact factor: 2.433

7.  Combination chemotherapy with irinotecan and ifosfamide as second-line treatment of refractory or sensitive relapsed small cell lung cancer: a phase II study.

Authors:  Masao Ichiki; Rumi Gohara; Toru Rikimaru; Takao Kitajima; Rei Fujiki; Akiko Shimada; Hisamichi Aizawa
Journal:  Chemotherapy       Date:  2003-07       Impact factor: 2.544

8.  Chromosome instability on children with asthma.

Authors:  Theodore Lialiaris; Aggeliki Polyzou; Panagiotis Mpountoukas; Anthi Tsiggene; Alexandros Kouskoukis; Stamatia Pouliliou; Emmanouil Paraskakis; Ioannis Tentes; Grigorios Trypsianis; Athanasios Chatzimichail
Journal:  J Asthma       Date:  2009-10       Impact factor: 2.515

9.  Supplementation of melatonin protects human lymphocytes in vitro from the genotoxic activity of melphalan.

Authors:  Theodore Lialiaris; Emmanuel Lyratzopoulos; Fotini Papachristou; Maria Simopoulou; Constantinos Mourelatos; Nikolaos Nikolettos
Journal:  Mutagenesis       Date:  2008-05-22       Impact factor: 3.000

10.  The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.

Authors:  Nancy Chen; Katarina Aleksa; Cindy Woodland; Michael Rieder; Gideon Koren
Journal:  Transl Res       Date:  2007-05-23       Impact factor: 7.012

View more
  2 in total

1.  A clinical and histopathological comparison of saline, adrenaline and 2-mercaptoethanesulfonate (MESNA) in mucoperichondrial elevation: which is superior?

Authors:  Zehra Çınar; Özgür Yiğit; Fulya Savran Turanoğlu; Sevim Baykal Koca
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

2.  In vivo anticlastogenic effect of silymarin from milk thistle Silybum marianum L.

Authors:  Sirajudheen Anwar; Hafez R Madkor; Nafees Ahmed; Mohamed E Wagih
Journal:  Indian J Pharmacol       Date:  2018 May-Jun       Impact factor: 1.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.